Cargando…
Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma
SIMPLE SUMMARY: To decipher the molecular mechanism underlying the resistance of a significant fraction of mantle cell lymphoma (MCL) patients to the first-in-class proteasome inhibitor bortezomib (BTZ), we have characterized the ubiquitin-related proteome (i.e., ubiquitome) of a set of MCL cell lin...
Autores principales: | Quinet, Grégoire, Xolalpa, Wendy, Reyes-Garau, Diana, Profitós-Pelejà, Núria, Azkargorta, Mikel, Ceccato, Laurie, Gonzalez-Santamarta, Maria, Marsal, Maria, Andilla, Jordi, Aillet, Fabienne, Bosch, Francesc, Elortza, Felix, Loza-Alvarez, Pablo, Sola, Brigitte, Coux, Olivier, Matthiesen, Rune, Roué, Gaël, Rodriguez, Manuel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869867/ https://www.ncbi.nlm.nih.gov/pubmed/35205670 http://dx.doi.org/10.3390/cancers14040923 |
Ejemplares similares
-
Mechanisms Regulating the UPS-ALS Crosstalk: The Role of Proteaphagy
por: Quinet, Grégoire, et al.
Publicado: (2020) -
Inhibition of the proteasome and proteaphagy enhances apoptosis in FLT3‐ITD‐driven acute myeloid leukemia
por: Lopez‐Reyes, Rosa G., et al.
Publicado: (2020) -
Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma
por: Santos, Juliana Carvalho, et al.
Publicado: (2022) -
RHOA Therapeutic Targeting in Hematological Cancers
por: Santos, Juliana Carvalho, et al.
Publicado: (2023) -
Proteaphagy is specifically regulated and requires factors dispensable for general autophagy
por: Waite, Kenrick A., et al.
Publicado: (2021)